The Company continues to strengthen its intellectual property portfolio for IGALMI™ (dexmedetomidine) sublingual film. The Company currently has 12 listed patents for IGALMI in the FDA’s Approved Drug ...
General Anesthesia Drugs MarketThe global general anesthesia drugs market, valued at USD 4,978.1 million in 2023, is poised for steady growth, with projections indicating a compound annual growth rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback